Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP lowered its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 4.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,434,466 shares of the company's stock after selling 168,455 shares during the quarter. Dimensional Fund Advisors LP owned 6.92% of Prestige Consumer Healthcare worth $210,260,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of PBH. GAMMA Investing LLC bought a new stake in Prestige Consumer Healthcare during the 4th quarter valued at $25,000. Provence Wealth Management Group purchased a new stake in shares of Prestige Consumer Healthcare during the third quarter worth about $26,000. Pacer Advisors Inc. grew its stake in shares of Prestige Consumer Healthcare by 85.7% in the fourth quarter. Pacer Advisors Inc. now owns 442 shares of the company's stock worth $27,000 after purchasing an additional 204 shares during the last quarter. Principal Securities Inc. purchased a new position in Prestige Consumer Healthcare during the 4th quarter valued at about $29,000. Finally, ORG Partners LLC bought a new position in Prestige Consumer Healthcare during the 4th quarter valued at approximately $36,000. Institutional investors own 99.95% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on PBH. StockNews.com upgraded Prestige Consumer Healthcare from a "buy" rating to a "strong-buy" rating in a report on Monday. TheStreet raised shares of Prestige Consumer Healthcare from a "c+" rating to a "b-" rating in a research note on Monday, February 12th. One research analyst has rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of "Buy" and an average price target of $110.00.

Prestige Consumer Healthcare Stock Down 7.0 %

PBH stock traded down $5.01 during midday trading on Wednesday, hitting $66.46. The stock had a trading volume of 824,483 shares, compared to its average volume of 239,073. The business has a 50-day moving average of $71.12 and a two-hundred day moving average of $65.18. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.09 and a quick ratio of 1.92. The firm has a market cap of $3.30 billion, a price-to-earnings ratio of -40.86, a price-to-earnings-growth ratio of 1.91 and a beta of 0.53. Prestige Consumer Healthcare Inc. has a 52-week low of $55.96 and a 52-week high of $75.31.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Tuesday, May 14th. The company reported $1.02 earnings per share for the quarter, missing analysts' consensus estimates of $1.14 by ($0.12). The business had revenue of $277.00 million during the quarter, compared to analysts' expectations of $287.42 million. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. The firm's quarterly revenue was down 3.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.07 earnings per share. As a group, equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.33 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.